Glycemic Control in Coronary Revascularization

Current Treatment Options in Cardiovascular Medicine
Francisco UjuetaBinita Shah

Abstract

Hyperglycemia in the setting of coronary revascularization is associated with increased adverse cardiovascular events in patients with or without diabetes mellitus. Data suggest that acute peri-procedural hyperglycemia causes an increase in inflammation, platelet activity, and endothelial dysfunction and is associated with plaque instability and infarct size. While peri-procedural blood glucose level is an independent predictor of adverse outcomes in patients undergoing coronary revascularization, treatment strategies remain uncertain. Randomized clinical trials of glucose-insulin-potassium infusions have consistently shown no benefit, while those comparing insulin therapy versus standard of care have demonstrated mixed results, likely due to the failure to reach euglycemia with these strategies. Although no glucose-lowering agent has been shown to be superior in peri-procedural glycemic control, the continuation of clinically prescribed long-acting glucose-lowering medications in patients with diabetes mellitus prior to coronary angiography and possible percutaneous coronary intervention may be the simplest and most effective approach to maintain euglycemia and decrease the associated increase in inflammation and platelet acti...Continue Reading

References

Oct 1, 1992·Journal of Cardiothoracic and Vascular Anesthesia·J O WistbackaL S Nuutinen
Mar 1, 1996·Journal of the American College of Cardiology·D AronsonE J Rayfield
Sep 19, 1998·Journal of the American College of Cardiology·A AbizaidM B Leon
Dec 19, 1998·Journal of the American College of Cardiology·S EleziA Schömig
May 10, 2002·The Annals of Thoracic Surgery·William A LellAlfred W Stanley
Jan 23, 2003·The Journal of Thoracic and Cardiovascular Surgery·Antonio Maria CalafioreStefano D'Alessandro
Sep 6, 2003·Journal of the American College of Cardiology·Iwan C C van der HorstUNKNOWN Zwolle Infarct Study Group
Jul 14, 2004·Archives of Internal Medicine·Kristen FranklinUNKNOWN GRACE Investigators
Aug 16, 2005·The American Journal of Cardiology·Binita ShahSteven P Sedlis
Nov 29, 2005·The American Journal of Cardiology·Mustafa YaziciMahmut Sahin
Jun 21, 2006·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Marianne YngenN Håkan Wallén
Feb 13, 2007·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Joseph LindsayRon Waksman
Aug 21, 2007·International Journal of Cardiology·Turgay CelikErsoy Isik
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
Sep 8, 2009·The American Journal of Cardiology·Masaharu IshiharaUNKNOWN Japanese Acute Coronary Syndrome Study (JACSS) Investigators
Apr 19, 2011·The Journal of Thoracic and Cardiovascular Surgery·Andrea SzékelyUNKNOWN Investigators of the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foun
Jun 18, 2011·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Annunziata NuscaGermano Di Sciascio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Related Papers

Journal of the American College of Cardiology
Antonio CerielloRoberto Testa
Giornale italiano di cardiologia : organo ufficiale della Federazione italiana di cardiologia : organo ufficiale della Società italiana di chirurgia cardiaca
Roberta Rossinidell’Associazione Medici Diabetologi (AMD) e della Società Italiana di Diabetologia (SID)
© 2021 Meta ULC. All rights reserved